October 21, 2010

Align Technology Announces Third Quarter Fiscal 2010 Results


Oct 21, 2010 (GlobeNewswire via COMTEX News Network) --

  --  Q3 revenues of $95.9 million increased 21.0% year-over-year
  --  Q3 Invisalign case shipments of 66.2 thousand increased 17.2%
      year-over-year
  --  Q3 gross margin of 78.1% increased 3.7% points year-over-year
  --  Q3 net profit of $16.8 million or $0.22 per share


SAN JOSE, Calif., Oct. 21, 2010 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) today reported financial results for the third quarter of fiscal 2010, ended September 30, 2010.

Total net revenues for the third quarter of fiscal 2010 (Q3 10) were $95.9 million compared to $108.2 million reported in the second quarter of 2010 (Q2 10) and compared to $79.3 million reported in the third quarter of 2009 (Q3 09). Q2 10 net revenues include the release of $14.3 million of previously deferred revenue for Invisalign Teen replacement aligners. Excluding this, Q2 10 non-GAAP revenues were $93.9 million. Invisalign case shipments for Q3 10 were 66.2 thousand, compared to 67.5 thousand in Q2 10 and compared to 56.5 thousand in Q3 09.

Net profit for Q3 10 was $16.8 million, or $0.22 per diluted share. This is compared to net profit of $32.6 million, or $0.42 per diluted share in Q2 10 and net loss of $49.9 million, or $0.72 per diluted share in Q3 09. Q3 10 net profit includes pre-tax litigation settlement costs of $3.3 million related to the settlement of a class action lawsuit announced today. Q2 10 net profit includes a pre-tax benefit of $14.3 million to net revenues from the release of previously deferred revenue related to Invisalign Teen replacement aligners, and a pre-tax credit of $8.7 million to operating expenses for an insurance settlement related to the OrthoClear litigation. Q3 09 net loss includes pre-tax litigation settlement costs of $69.7 million, pre-tax royalties of $1.9 million and additional tax benefit of $12.7 million, for a total of $0.85 per diluted share related to the settlement agreement with Ormco Corporation.

"I'm pleased to report another good quarter of financial results for Align with revenue, gross margin, operating margin, and EPS above our outlook," said Thomas M. Prescott, Align president and CEO. "Case shipments were within our guidance range, though at the lower end, reflecting growth from North American Orthodontists and International doctors, offset primarily by greater than expected summer seasonality. This softness has persisted into the fall, especially among our North American GP dentists who have reported lower dental visits and reduced demand for premium procedures, which we believe contributed to lower than expected case submissions for Invisalign as well."

To supplement our consolidated financial statements, we use the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating expense, non-GAAP operating margin, non-GAAP net profit and non-GAAP earnings per share. Detailed reconciliations between GAAP and non-GAAP information are contained in the tables following the financial tables of this release.

Non-GAAP net profit for Q3 10 was $19.3 million, or $0.25 per diluted share. This is compared to non-GAAP net profit of $16.5 million, or $0.21 per diluted share in Q2 10 and non-GAAP net profit of $8.9 million, or $0.13 per diluted share in Q3 09.


  Q3 10 Operating Results
  ----------------------------


  ----------------------------  ------  -------  --------

  Key GAAP Operating Results     Q3 10   Q2 10    Q3 09
                                ------  -------  --------
  Revenue                       $95.9M  $108.2M    $79.3M
  Gross Margin                   78.1%    80.4%     74.4%
  Operating Expense             $53.0M   $41.7M   $119.2M
  Operating Margin               22.8%    41.9%   (75.9%)
  Net Profit (Loss)             $16.8M   $32.6M  ($49.9M)
  Earnings (Loss) Per Diluted
   Share (EPS)                   $0.22    $0.42   ($0.72)

  Key Non-GAAP Operating
   Results                       Q3 10   Q2 10    Q3 09
                                ------  -------  --------
  Non-GAAP Revenue**            $95.9M   $93.9M    $79.3M

  Non-GAAP Gross Margin          78.1%    77.4%     76.8%
                                ------  -------  --------
  Non-GAAP Operating Expense    $49.7M   $50.3M    $49.5M
  Non-GAAP Operating Margin      26.3%    23.8%     14.4%
  Non-GAAP Net Profit           $19.3M   $16.5M     $8.9M
  Non-GAAP Earnings Per
   Diluted Share (EPS)           $0.25    $0.21     $0.13

Total stock-based compensation expense included in Q3 10 was $4.4 million compared to $4.3 million in Q2 10 and compared to $4.0 million in Q3 09. Stock based compensation expense included in GAAP gross margin in Q3 10 was $0.4 million, compared to $0.4 million in Q2 10 and $0.4 million in Q3 09. Stock-based compensation expense included in GAAP operating expense in Q3 10 was $4.0 million compared to $3.9 million in Q2, and $3.6 million in Q3 09.

Liquidity and Capital Resources

As of September 30, 2010, Align had $280.1 million in cash, cash equivalents, and marketable securities compared to $186.5 million as of December 31, 2009.

Key Business Metrics

The following table highlights business metrics for Align's third quarter of 2010. Additional historical information is available on the Company's website at http://investor.aligntech.com.



  ------------------------------  ------  ----------  -------


  ------------------------------  ------  ----------  -------
                                                         Q3
                                                       10/Q2
  Revenue by Channel ($M):         Q3 10  % of Total   10**

                                                         %
                                           Revenue     Change
                                  ------  ----------  -------

  North American Orthodontists     $31.1     32.5%     7.0%
  North American GP Dentists       $36.8     38.3%     (1.6%)
  International                    $23.2     24.2%     5.5%

  Non-case Revenue*                $4.8      5.0%     (11.1%)
                                  ------  ----------  -------

  Total Revenue**                  $95.9     100%      2.2%
                                  ======  ==========  =======

                                                         Q3
                                                       10/Q2
  Revenue by Product ($M):         Q3 10  % of Total   10**

                                                         %
                                           Revenue     Change
                                  ------  ----------  -------

  Invisalign Full                  $66.6     69.5%     (1.3%)
  Invisalign Express/Lite          $8.9      9.3%      1.5%
  Invisalign Teen                  $11.3     11.8%     34.8%
  Invisalign Assist                $4.3      4.4%      12.9%

  Non-case Revenue*                $4.8      5.0%     (11.1%)
                                  ------  ----------  -------

  Total Revenue                    $95.9     100%      2.2%
                                  ======  ==========  =======
  *includes training, ancillary products, and retainers
  **Q210 excludes the release of $14.3M of previously
   deferred revenue for Invisalign Teen replacement aligners

                                                         Q3
                                                       10/Q2
  Cases Shipped by Channel:        Q3 10  % of Total     10

                                                         %
                                             Cases     Change
                                  ------  ----------  -------

  North American Orthodontists    23,155     35.0%     0.3%
  North American GP Dentists      26,840     40.5%     (5.7%)

  International                   16,245     24.5%     1.9%
                                  ------  ----------  -------

  Total Cases Shipped             66,240     100%      (1.8%)
                                  ======  ==========  =======

                                                         Q3
                                                       10/Q2
  Cases Shipped by Product:        Q3 10  % of Total     10

                                                         %
                                             Cases     Change
                                  ------  ----------  -------
  Invisalign Full                 44,940     67.8%     (4.5%)
  Invisalign Express/Lite          9,765     14.7%     1.9%
  Invisalign Teen                  7,590     11.5%     11.4%

  Invisalign Assist                3,945     6.0%      (1.9%)
                                  ------  ----------  -------

  Total Cases Shipped             66,240     100%      (1.8%)
                                  ======  ==========  =======

  Average Selling Price (ASP),
   as billed:                      Q3 10
                                  ------
  Total Worldwide Blended ASP     $1,390
  International ASP               $1,430

  Number of Doctors Cases were
   Shipped to:                     Q3 10
                                  ------
  North American Orthodontists     3,985
  North American GP Dentists      10,035

  International                    4,245
                                  ------
  Total Doctors Cases were
   Shipped to Worldwide           18,265
                                  ======

  Doctor Utilization Rates*:       Q3 10     Q2 10     Q3 09
  North American Orthodontists     5.8       5.8        4.9
  North American GP Dentists       2.7       2.8        2.3

  International                    3.8       3.8        3.5
                                  ------  ----------  -------

  Total Utilization Rate           3.6       3.7        3.1
                                  ======  ==========  =======
  * Utilization = # of cases shipped/# of doctors to whom
   cases were shipped

  Number of Doctors Trained
   Worldwide:                      Q3 10  Cumulative
                                  ------  ----------  -------
  North American Orthodontists     105       9,195
  North American GP Dentists       445      36,455

  International                    275      16,940
                                  ------  ----------  -------
  Total Doctors Trained
   Worldwide                       825      62,590
                                  ======  ==========  =======

  Total Invisalign Patients
   (cases shipped):                Q3 10  Cumulative
                                  ======  ==========
  Number of Patients Treated or
   in Treatment (cases)           66,240   1,362,030
                                  ======  ==========


Q4 Fiscal 2010 Business Outlook

For the fourth quarter of fiscal 2010 (Q4 10), Align Technology expects net revenues to be in a range of $90.5 million to $93.0 million. GAAP earnings per diluted share for Q4 10 is expected to be in a range of $0.15 to $0.17. A more comprehensive business outlook is available following the financial tables of this release.

Long Term Financial Model

Over the past two years, Align has made significant progress towards its long term financial model targets and has consistently delivered financial results at the high-end or slightly above the long term model ranges. As part of Align's annual strategic planning process, senior management evaluates the model and determines whether it is still appropriate in terms of expected top line growth, strategic investment, and return to shareholders. Given Align's recent performance and updated long-term strategy, the Company remains confident about its future and has revised the 3 to 5 year long term financial model as follows:



  --------------------------  --------------  --------------

  3 -- 5 Year Long Term
   Model                           Prior           New
  --------------------------  --------------  --------------

  Revenue CAGR%                  10% - 20%       15% - 25%
                              --------------  --------------

  Non GAAP Gross Margin          73% - 78%       73% - 78%
                              --------------  --------------

  Non GAAP Op Ex %               55% - 60%       45% - 50%
                              --------------  --------------

  Non GAAP Op Margin             15% - 20%       25% - 30%
                              --------------  --------------

Align Web Cast and Conference Call

Align Technology will host a conference call today, October 21, 2010 at 4:30 p.m. ET, 1:30 p.m. PT, to review its third quarter fiscal 2010 results, discuss future operating trends and business outlook. The conference call will also be web cast live via the Internet. To access the web cast, go to the "Events & Presentations" section under Company Information on Align Technology's Investor Relations web site at http://investor.aligntech.com. To access the conference call, please dial 201-689-8261 approximately fifteen minutes prior to the start of the call. If you are unable to listen to the call, an archived web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with account number 292 followed by # and conference number 358000 followed by #. The replay must be accessed from international locations by dialing 201-612-7415 and using the same account and conference numbers referenced above. The telephonic replay will be available through 5:30 p.m. ET on November 4, 2010.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Today, the Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express, and Vivera Retainers.

To learn more about Invisalign or to find an Invisalign trained doctor in your area, please visit www.invisalign.com or call 1-800-INVISIBLE.

About non-GAAP Financial Measures

To supplement our consolidated financial statements and our business outlook, we use the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating expenses, non-GAAP profit from operations, non-GAAP net profit, and non-GAAP earnings per share, which exclude, as applicable, the impact of an litigation settlement from a class action lawsuit, the release of previously deferred revenue of Invisalign Teen royalties associated with the settlement with Ormco, the impact of an insurance settlement, and any related tax effects. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. For more information on these non-GAAP financial measures, please see the tables captioned "Business Outlook Summary" included at the end of this release.

We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our "core operating performance". Management believes that "core operating performance" represents Align's performance in the ordinary, ongoing and customary course of its operations. Accordingly, management excludes from "core operating performance" certain expenditures, revenues and other items that may not be indicative of our operating performance including discrete cash and non-cash charges that are infrequent or one-time in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal evaluation of period-to-period comparisons. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making and (2) they are provided to and used by our institutional investors and the analyst community to facilitate comparisons with prior and subsequent reporting periods.

Forward-Looking Statement

This news release, including the tables below, contains forward-looking statements, including statements regarding, certain business metrics for the fourth quarter of 2010, including anticipated revenue, gross margin, operating expense, operating income, earnings per share, case shipments and cash. Forward-looking statements contained in this news release and the tables below relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement. Factors that might cause such a difference include, but are not limited to, difficulties predicting customer and consumer purchasing behavior, the willingness and ability of our customers to maintain and/or increase utilization in sufficient numbers, the possibility that the development and release of new products does not proceed in accordance with the anticipated timeline, the possibility that the market for the sale of these new products may not develop as expected, the risks relating to Align's ability to sustain or increase profitability or revenue growth in future periods while controlling expenses, continued customer demand for Invisalign and new products, changes in consumer spending habits as a result of, among other things, prevailing economic conditions, levels of employment, salaries and wages and consumer confidence, the timing of case submissions from our doctors within a quarter, acceptance of Invisalign by consumers and dental professionals, foreign operational, political and other risks relating to Align's international manufacturing operations, Align's ability to protect its intellectual property rights, competition from manufacturers of traditional braces and new competitors, Align's ability to develop and successfully introduce new products and product enhancements, and the loss of key personnel. These and other risks are detailed from time to time in Align's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, its Annual Report on Form 10-K for the fiscal year ended December 31, 2009, which was filed with the Securities and Exchange Commission on February 26, 2010. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.


  ALIGN TECHNOLOGY, INC.
  UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
  (in thousands, except per share data)


                                 Three Months Ended       Nine Months Ended
                               ----------------------  -----------------------

                               September   September    September   September
                                  30,         30,         30,          30,
                                  2010       2009         2010        2009
                               ---------  -----------  ----------  -----------
  Net revenues                  $ 95,947     $ 79,269   $ 294,233    $ 225,717


  Cost of revenues                21,014       20,268      62,572       56,031
                               ---------  -----------  ----------  -----------


  Gross profit                    74,933       59,001     231,661      169,686
                               ---------  -----------  ----------  -----------

  Operating expenses:
   Sales and marketing            26,905       27,687      83,790       84,649
   General and administrative     16,203       16,224      46,159       46,231
   Research and development        6,592        5,611      19,104       16,471
   Restructuring                      --           --          --        1,319
   Litigation settlement           3,310       69,673       3,310       69,673

   Insurance settlement               --           --     (8,666)           --
                               ---------  -----------  ----------  -----------

  Total operating expenses        53,010      119,195     143,697      218,343
                               ---------  -----------  ----------  -----------

  Profit (loss) from
   operations                     21,923     (60,194)      87,964     (48,657)

  Interest and other income
   (expense), net                   (83)        (271)       (480)          434
                               ---------  -----------  ----------  -----------

  Profit (loss) before income
   taxes                          21,840     (60,465)      87,484     (48,223)

  Provision for (benefit
   from) income taxes              5,025     (10,523)      23,136      (5,462)
                               ---------  -----------  ----------  -----------


  Net profit (loss)             $ 16,815   $ (49,942)    $ 64,348   $ (42,761)
                               =========  ===========  ==========  ===========

  Net profit (loss) per share

   - basic                        $ 0.22     $ (0.72)      $ 0.85     $ (0.64)
                               =========  ===========  ==========  ===========

   - diluted                      $ 0.22     $ (0.72)      $ 0.83     $ (0.64)
                               =========  ===========  ==========  ===========

  Shares used in computing
   net profit/loss per share

   - basic                        76,081       69,528      75,653       67,278
                               =========  ===========  ==========  ===========

   - diluted                      78,109       69,528      77,852       67,278
                               =========  ===========  ==========  ===========



  ALIGN TECHNOLOGY, INC.
  UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
  (in thousands)

                                September   December
                                  30,         31,
                                  2010        2009

             ASSETS
                               ----------  ----------

  Current assets:
   Cash and cash equivalents    $ 264,924   $ 166,487
   Marketable securities,
    short-term                      7,396      19,978
   Accounts receivable, net        63,811      54,537
   Inventories                      2,382       2,046

   Other current assets            19,429      18,251
                               ----------  ----------
    Total current assets          357,942     261,299

  Marketable securities,
   long-term                        7,829          --
  Property and equipment, net      28,102      24,971
  Goodwill and intangible
   assets, net                      3,366       5,466
  Deferred tax asset               43,778      61,535

  Other long-term assets            4,218       1,969
                               ----------  ----------


    Total assets                $ 445,235   $ 355,240
                               ==========  ==========


        LIABILITIES AND
      STOCKHOLDERS' EQUITY

  Current liabilities:
   Accounts payable               $ 5,826     $ 6,122
   Accrued liabilities             44,074      42,822

   Deferred revenue                30,136      32,299
                               ----------  ----------
    Total current liabilities      80,036      81,243


  Other long term liabilities       5,797         961
                               ----------  ----------
    Total liabilities              85,833      82,204


  Total stockholders' equity      359,402     273,036
                               ----------  ----------

    Total liabilities and
     stockholders' equity       $ 445,235   $ 355,240
                               ==========  ==========



  ALIGN TECHNOLOGY, INC.
  RECONCILIATION OF GAAP TO NON-GAAP KEY FINANCIAL METRICS

  Reconciliation of GAAP to
   Non-GAAP Net Revenues
  (in thousands)

                                       Three Months Ended
                               ----------------------------------

                               September               September
                                  30,      June 30,       30,
                                  2010       2010        2009
                               ---------  ----------  -----------

  Net revenues                  $ 95,947   $ 108,196     $ 79,269
   Teen deferred revenue
    release                           --    (14,298)           --
                               ---------  ----------  -----------

  Non-GAAP net revenues         $ 95,947    $ 93,898     $ 79,269
                               =========  ==========  ===========

  Reconciliation of GAAP to
   Non-GAAP Gross Profit
  (in thousands)

                                       Three Months Ended
                               ----------------------------------

                               September               September
                                  30,      June 30,       30,
                                  2010       2010        2009
                               ---------  ----------  -----------
  GAAP Gross profit             $ 74,933    $ 87,018     $ 59,001
   Teen deferred revenue
    release                           --    (14,298)           --

   Ormco royalties                    --          --        1,906
                               ---------  ----------  -----------

  Non-GAAP Gross profit         $ 74,933    $ 72,720     $ 60,907
                               =========  ==========  ===========

  Reconciliation of GAAP to
   Non-GAAP Operating
   Expenses
  (in thousands)

                                       Three Months Ended
                               ----------------------------------

                               September               September
                                  30,      June 30,       30,
                                  2010       2010        2009
                               ---------  ----------  -----------

  GAAP Operating expenses       $ 53,010    $ 41,674    $ 119,195
   Litigation settlement         (3,310)          --     (69,673)

   Insurance settlement               --       8,666           --
                               ---------  ----------  -----------

  Non-GAAP Operating expenses   $ 49,700    $ 50,340     $ 49,522
                               =========  ==========  ===========

  Reconciliation of GAAP to
   Non-GAAP Profit from
   Operations
  (in thousands)

                                       Three Months Ended
                               ----------------------------------

                               September               September
                                  30,      June 30,       30,
                                  2010       2010        2009
                               ---------  ----------  -----------
  GAAP Profit (loss) from
   operations                   $ 21,923    $ 45,344   $ (60,194)
   Teen deferred revenue
    release                           --    (14,298)           --
   Ormco royalties                    --          --        1,906
   Litigation settlement           3,310          --       69,673

   Insurance settlement               --     (8,666)           --
                               ---------  ----------  -----------
  Non-GAAP Profit from
   operations                   $ 25,233    $ 22,380     $ 11,385
                               =========  ==========  ===========

  Reconciliation of GAAP to
   Non-GAAP Net Profit
  (in thousands, except per
   share amounts)

                                       Three Months Ended
                               ----------------------------------

                               September               September
                                  30,      June 30,       30,
                                  2010       2010        2009
                               ---------  ----------  -----------
  GAAP Net profit (loss)        $ 16,815    $ 32,603   $ (49,942)
   Teen deferred revenue
    release                           --    (14,298)           --
   Ormco royalties                    --          --        1,906
   Litigation settlement           3,310          --       69,673
   Insurance settlement               --     (8,666)           --
   Tax effect on non-GAAP
    adjustments                    (790)       6,816     (12,731)
                               ---------  ----------  -----------

  Non-GAAP Net profit           $ 19,335    $ 16,455      $ 8,906
                               =========  ==========  ===========

  Diluted Net profit (loss)
   per share:

   GAAP                           $ 0.22      $ 0.42     $ (0.72)
                               =========  ==========  ===========

   Non-GAAP                       $ 0.25      $ 0.21       $ 0.13
                               =========  ==========  ===========

  Shares used in computing
   diluted GAAP net
   profit/loss per share          78,109      77,607       69,528
                               =========  ==========  ===========
  Shares used in computing
   diluted non-GAAP net
   profit per share               78,109      77,607       70,926
                               =========  ==========  ===========

  ALIGN TECHNOLOGY, INC.
  BUSINESS OUTLOOK SUMMARY
  (unaudited)

  Bitmap The outlook figures provided below and elsewhere in this press
   release are approximate in nature since Align's business outlook is
   difficult to predict.
  Align's future performance involves numerous risks and uncertainties and
   the company's results could differ materially from the outlook provided.
  Some of the factors that could affect Align's future financial performance
   and business outlook are set forth under "Forward Looking Information"
   above in this press release.

  Financials
  (in millions, except per share amounts and
   percentages)

                                       Q4 2010
                                  ------------------
  Net Revenue                       $90.5 -- $93.0

  Gross Profit                      $68.8 -- $71.2

  Gross Margin                       76.0% - 76.5%

  Operating Expenses                $51.5 -- $52.5

  Operating Margin                   19.1% - 20.0%

  Net Income per Diluted
   Share                            $0.15 -- $0.17

  Stock Based Compensation
   Expense:
  Cost of Revenues                       $0.4

  Operating Expenses                     $3.8
                                  ------------------
  Total Stock Based Compensation
   Expense                               $4.2

  Business Metrics:

                                       Q4 2010
                                  ------------------
  Case Shipments                     61.5K - 63K
  Cash                              $295M -- $300M
  Capex                             $4.0M -- $6.0M
  Depreciation & Amortization       $2.0M -- $3.0M
  Diluted Shares Outstanding             78.5M


  Full Year 2010:                      FY 2010
                                  ------------------

  Stock Based compensation              $16.5M
  Diluted Shares Outstanding             78M

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: Align Technology

CONTACT:  Align Technology, Inc.
Investor Relations Contact
Shirley Stacy
(408) 470-1150
sstacy@aligntech.com
Ethos Communication, Inc.
Shannon Mangum Henderson
Press Contact
(678) 261-7803
align@ethoscommunication.com

(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.

News Provided by COMTEX


Close window | Back to top

Copyright 2017 Align Technology, Inc.